Opportunistic Screening for Medically Actionable Secondary Genomic Findings

Explore the complexities of communicating medically actionable secondary genomic findings in this 55-minute webinar presented by Ambry Genetics. Gain insights into the current literature on how these findings are shared with recipients in clinical and research settings. Compare reported outcomes against desired results, including appropriate screening uptake, family communication, and cascade testing. Identify gaps in existing research and discover opportunities for genetic counselors to lead innovative studies that enhance the potential of secondary findings in precision medicine. Learn from Julie Sapp, ScM, CGC, a genetic counselor at the National Human Genome Research Institute, as she shares her expertise in therapeutics for ultra-rare disorders, research ethics, and informed consent. Moderated by Shreya Malhotra, MS, an oncology genomic science liaison at Ambry Genetics, this webinar offers valuable knowledge for healthcare professionals interested in advancing the field of genomic medicine and improving patient outcomes.

Opportunistic Screening for Medically Actionable Secondary Genomic Findings | Ambry Genetics